Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

GENERATE - Næste GENERATION af gynækologisk kirurgi - Robotassisteret kirurgi i gynækologiske indikationer (GENERATE)

2. november 2026 opdateret af: Intuitive Surgical

GENERETER - Næste GENERATION af gynækologisk kirurgi - Robotassisteret kirurgi i gynækologiske indikationer - En prospektiv, ikke-interventionel, multicenter, postmarkedsklinisk undersøgelse

GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications

Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

A prospective, non-interventional, multi-center, post market clinical study.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

1250

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Berlin, Tyskland, 13353
        • Aktiv, ikke rekrutterende
        • Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
      • Bochum, Tyskland, 44791
        • Aktiv, ikke rekrutterende
        • Augusta-Kranken-Anstalt Bochum
      • Coburg, Tyskland, 96450
        • Aktiv, ikke rekrutterende
        • Sana Kliniken Coburg
      • Cologne, Tyskland, 50935
        • Afsluttet
        • St. Elisabeth-Krankenhaus Köln-Hohenlind
      • Essen, Tyskland, 45147
        • Aktiv, ikke rekrutterende
        • Universitätsklinikum Essen
      • Frankfurt am Main, Tyskland, 60431
        • Aktiv, ikke rekrutterende
        • Agaplesion Markus Krankenhaus Frankfurt am Main
      • Freiburg im Breisgau, Tyskland, 79106
        • Rekruttering
        • Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
        • Kontakt:
          • Markus Hübner, Prof. Dr.
      • Greifswald, Tyskland, 17475
      • Höxter, Tyskland, 37671
        • Aktiv, ikke rekrutterende
        • St. Ansgar Krankenhaus Höxter
      • Kiel, Tyskland, 24105
        • Aktiv, ikke rekrutterende
        • Universitätsklinikum Kiel
      • Nuremberg, Tyskland, 90419
        • Aktiv, ikke rekrutterende
        • Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
      • Schwerin, Tyskland, 19055
        • Aktiv, ikke rekrutterende
        • Helios Kliniken Schwerin
      • Tübingen, Tyskland, 72076
        • Aktiv, ikke rekrutterende
        • Universitätsklinikum Tübingen - Frauenklinik
    • Free and Hanseatic City of Hamburg
      • Hamburg, Free and Hanseatic City of Hamburg, Tyskland, 22457
        • Aktiv, ikke rekrutterende
        • Albertinen Krankenhaus Hamburg
    • Hesse
      • Wiesbaden, Hesse, Tyskland, 65189
        • Aktiv, ikke rekrutterende
        • St. Josefs-Hospital Wiesbaden

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

Patients with gynecological disease that may be treated by surgical intervention.

Beskrivelse

Key Inclusion Criteria:

  • Woman with 18 years of age or older
  • Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
  • Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System

Key Exclusion Criteria:

  • Life expectancy of less than 1 year
  • Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
  • Current participation in a clinical study, if not pre-approved by Intuitive
  • Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
da Vinci Patients

Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery

Robotic-assisted surgery (da Vinci)

Epidemiological Data Audit

Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery

Non-da Vinci Surgery

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of complications related to the surgery up to 30 days
Tidsramme: 30 days

Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed.

30 days
Describe the number of patient-reported outcomes up to 12 months
Tidsramme: 12 months

Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication

12 months
Characterize the treatment decision as reported by the treating physician
Tidsramme: 30 days

Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed

30 days

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Investigate the impact of patient characteristics on surgery
Tidsramme: 30 days

Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage)

30 days
Investigate the impact of patient characteristics on clinical outcome
Tidsramme: 30 days

Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation)

30 days
Investigate the impact of patient characteristics on complications
Tidsramme: 30 days

Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery)

30 days
Describe the impact from surgery to the patient's quality of life and function
Tidsramme: 12 months

Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months)

12 months
Describe the number of Intuitive instruments used per procedure and patient characteristics
Tidsramme: 30 days

Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient

30 days
Describe the number of disease recurrence and re-operation at final patient follow-up
Tidsramme: 12 months

Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed

12 months
Describe the number of conversion per procedure and patient characteristics
Tidsramme: 30 days

Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed

30 days
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
Tidsramme: 30 days

Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon

30 days
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
Tidsramme: 30 days

Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon

30 days
Describe the impact of surgeon experience on complications (number of events per surgeon)
Tidsramme: 30 days

Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon

30 days

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Ingolf Juhasz-Böss, Prof. Dr., University Hospital Freiburg

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

25. oktober 2023

Primær færdiggørelse (Anslået)

1. februar 2028

Studieafslutning (Anslået)

1. juli 2028

Datoer for studieregistrering

Først indsendt

2. maj 2023

Først indsendt, der opfyldte QC-kriterier

10. maj 2023

Først opslået (Faktiske)

22. maj 2023

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

4. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ja

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner